This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Pituitary gland, craniopharyngeal duct (controls excluding all cancers)
CD2_BENIGN_PITUITARY_CRANIPHAR_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
Hospital discharge: ICD-9
2273
Hospital discharge: ICD-8
2262
Cause of death: ICD-9
2273
Cause of death: ICD-8
2262
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
1402
CD2_BENIGN_PITUITARY_CRANIPHAR_EXALLC
Control definitions
Control exclude
C3_CANCER
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pituitary gland, craniopharyngeal duct (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Benign neoplasm: Pituitary gland, craniopharyngeal duct
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasm of other and unspecified endocrine glands (controls excluding all cancers)
- Benign neoplasms (controls excluding all cancers)
- Benign neoplasms
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1402 | 814 | 588 |
| Unadjusted prevalence (%) | 0.37 | 0.39 | 0.35 |
| Mean age at first event (years) | 50.31 | 47.22 | 54.57 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_PITUITARY_CRANIPHAR_EXALLC – Benign neoplasm: Pituitary gland, craniopharyngeal duct (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm: Pituitary gland, craniopharyngeal duct (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.